Search Results - "Pais, Pedro"

Refine Results
  1. 1

    Saccharomyces boulardii: What Makes It Tick as Successful Probiotic? by Pais, Pedro, Almeida, Vanda, Yilmaz, Melike, Teixeira, Miguel C

    Published in Journal of fungi (Basel) (01-06-2020)
    “…Saccharomyces boulardii is a probiotic yeast often used for the treatment of GI tract disorders such as diarrhea symptoms. It is genetically close to the model…”
    Get full text
    Journal Article
  2. 2
  3. 3

    YEASTRACT: an upgraded database for the analysis of transcription regulatory networks in Saccharomyces cerevisiae by Teixeira, Miguel C, Monteiro, Pedro T, Palma, Margarida, Costa, Catarina, Godinho, Cláudia P, Pais, Pedro, Cavalheiro, Mafalda, Antunes, Miguel, Lemos, Alexandre, Pedreira, Tiago, Sá-Correia, Isabel

    Published in Nucleic acids research (04-01-2018)
    “…Abstract The YEAst Search for Transcriptional Regulators And Consensus Tracking (YEASTRACT-www.yeastract.com) information system has been, for 11 years, a key…”
    Get full text
    Journal Article
  4. 4

    Divergent Approaches to Virulence in C. albicans and C. glabrata : Two Sides of the Same Coin by Galocha, Mónica, Pais, Pedro, Cavalheiro, Mafalda, Pereira, Diana, Viana, Romeu, Teixeira, Miguel C

    “…and are the two most prevalent etiologic agents of candidiasis worldwide. Although both are recognized as pathogenic, their choice of virulence traits is…”
    Get full text
    Journal Article
  5. 5

    Evaluating optimizations that reduce global memory accesses of stencil computations in GPGPUs by Carrijo Nasciutti, Thiago, Panetta, Jairo, Pais Lopes, Pedro

    Published in Concurrency and computation (25-09-2019)
    “…Summary This work compares the performance of optimizations that transform replicated global memory accesses into local memory accesses on 3D stencil…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The PathoYeastract database: an information system for the analysis of gene and genomic transcription regulation in pathogenic yeasts by Monteiro, Pedro Tiago, Pais, Pedro, Costa, Catarina, Manna, Sauvagya, Sá-Correia, Isabel, Teixeira, Miguel Cacho

    Published in Nucleic acids research (04-01-2017)
    “…We present the PATHOgenic YEAst Search for Transcriptional Regulators And Consensus Tracking (PathoYeastract - http://pathoyeastract.org) database, a tool for…”
    Get full text
    Journal Article
  8. 8

    Membrane Proteome-Wide Response to the Antifungal Drug Clotrimazole in Candida glabrata: Role of the Transcription Factor CgPdr1 and the Drug:H+ Antiporters CgTpo1_1 and CgTpo1_2 by Pais, Pedro, Costa, Catarina, Pires, Carla, Shimizu, Kiminori, Chibana, Hiroji, Teixeira, Miguel C.

    Published in Molecular & cellular proteomics (01-01-2016)
    “…Azoles are widely used antifungal drugs. This family of compounds includes triazoles, mostly used in the treatment of systemic infections, and imidazoles, such…”
    Get full text
    Journal Article
  9. 9

    Chronic nasopharyngeal and otitis media tuberculosis: diagnosis and management difficulties by Pais, José Pedro, Caçador, Maria, Mourato, Teresa, Paço, João

    Published in BMJ case reports (25-08-2022)
    “…Nasopharyngeal and otitis media tuberculosis are rare extrapulmonary manifestations of infection. We present a case of a middle-aged woman with manifestations…”
    Get full text
    Journal Article
  10. 10

    New Mechanisms of Flucytosine Resistance in C. glabrata Unveiled by a Chemogenomics Analysis in S. cerevisiae by Costa, Catarina, Ponte, Andreia, Pais, Pedro, Santos, Rui, Cavalheiro, Mafalda, Yaguchi, Takashi, Chibana, Hiroji, Teixeira, Miguel Cacho

    Published in PloS one (12-08-2015)
    “…5-Flucytosine is currently used as an antifungal drug in combination therapy, but fungal pathogens are rapidly able to develop resistance against this drug,…”
    Get full text
    Journal Article
  11. 11

    Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection by Pais, Pedro, Galocha, Mónica, Viana, Romeu, Cavalheiro, Mafalda, Pereira, Diana, Teixeira, Miguel Cacho

    Published in Microbial cell (08-02-2019)
    “…Infections by the pathogenic yeasts and are among the most common fungal diseases. The success of these species as human pathogens is contingent on their…”
    Get full text
    Journal Article
  12. 12

    Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection by Pais, João Pedro, Policarpo, Margarida, Pires, David, Francisco, Ana Paula, Madureira, Ana Margarida, Testa, Bernard, Anes, Elsa, Constantino, Luís

    Published in Pharmaceuticals (Basel, Switzerland) (30-09-2022)
    “…Tuberculosis (TB) is currently one of the leading causes of death due to infective agents, and the growing rate of multidrug-resistant tuberculosis (MDR TB)…”
    Get full text
    Journal Article
  13. 13

    Membrane Proteomics Analysis of the Candida glabrata Response to 5-Flucytosine: Unveiling the Role and Regulation of the Drug Efflux Transporters CgFlr1 and CgFlr2 by Pais, Pedro, Pires, Carla, Costa, Catarina, Okamoto, Michiyo, Chibana, Hiroji, Teixeira, Miguel C

    Published in Frontiers in microbiology (21-12-2016)
    “…Resistance to 5-flucytosine (5-FC), used as an antifungal drug in combination therapy, compromises its therapeutic action. In this work, the response of the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Multiple genome analysis of Candida glabrata clinical isolates renders new insights into genetic diversity and drug resistance determinants by Pais, Pedro, Galocha, Mónica, Takahashi-Nakaguchi, Azusa, Chibana, Hiroji, Teixeira, Miguel C.

    Published in Microbial cell (07-11-2022)
    “…The emergence of drug resistance significantly hampers the treatment of human infections, including those caused by fungal pathogens such as Candida species…”
    Get full text
    Journal Article
  16. 16

    A new regulator in the crossroads of oxidative stress resistance and virulence in Candida glabrata: The transcription factor CgTog1 by Pais, Pedro, Vagueiro, Susana, Mil-Homens, Dalila, Pimenta, Andreia I., Viana, Romeu, Okamoto, Michiyo, Chibana, Hiroji, Fialho, Arsénio M., Teixeira, Miguel C.

    Published in Virulence (01-12-2020)
    “…Candida glabrata is a prominent pathogenic yeast which exhibits a unique ability to survive the harsh environment of host immune cells. In this study, we…”
    Get full text
    Journal Article
  17. 17

    Transcriptional Control of Drug Resistance, Virulence and Immune System Evasion in Pathogenic Fungi: A Cross-Species Comparison by Pais, Pedro, Costa, Catarina, Cavalheiro, Mafalda, Romão, Daniela, Teixeira, Miguel C

    “…Transcription factors are key players in the control of the activation or repression of gene expression programs in response to environmental stimuli. The…”
    Get full text
    Journal Article
  18. 18

    A New Determinant of Candida glabrata Virulence: The Acetate Exporter CgDtr1 by Romão, Daniela, Cavalheiro, Mafalda, Mil-Homens, Dalila, Santos, Rui, Pais, Pedro, Costa, Catarina, Takahashi-Nakaguchi, Azusa, Fialho, Arsénio M, Chibana, Hiroji, Teixeira, Miguel C

    “…Persistence and virulence of infections are multifactorial phenomena, whose understanding is crucial to design more suitable therapeutic strategies. In this…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Characterization of the Candida glabrata Transcription Factor CgMar1: Role in Azole Susceptibility by Pais, Pedro, Galocha, Mónica, Califórnia, Raquel, Viana, Romeu, Ola, Mihaela, Okamoto, Michiyo, Chibana, Hiroji, Butler, Geraldine, Teixeira, Miguel C

    Published in Journal of fungi (Basel) (07-01-2022)
    “…The prevalence of antifungal resistance in , especially against azole drugs, results in difficult-to-treat and potentially life-threatening infections…”
    Get full text
    Journal Article